Lixisenatide (Adlyxin) – A Once-Daily GLP-1 Agonist for Diabetes

 Lixisenatide (Adlyxin) is a short-acting GLP-1 receptor agonist used to improve glycemic control in type 2 diabetes. It helps enhance insulin release while reducing glucose levels post-meal.

How Lixisenatide Works

Lixisenatide slows gastric emptying, preventing rapid sugar absorption. It also increases insulin production in response to high glucose levels.

Advantages of Lixisenatide

• Improves Post-Meal Glucose Control – Reduces blood sugar spikes.
• Convenient Dosing – A once-daily injection simplifies treatment.
• May Support Weight Loss – Reduces hunger and calorie intake.

Potential Downsides

Patients may experience nausea, vomiting, and diarrhea. Hypoglycemia risk increases when used with sulfonylureas or insulin.

Lixisenatide is an effective option for patients needing additional glucose control without major weight gain risks.